intracellular ABSs
search of GPCR ABSs
allosteric modulators
drugs binding
action
MIDAS
distinct allosteric binding sites
available X-ray structures
Predictive modelling of GPCR druggable allosteric sites G protein
CCR5 receptors
non-specific binding
GCGR receptors
crystal structures
cosolvent mapping
GPCR helices
recent release of X-ray structures of GPCRs
orthosteric sites
discovery of safer drugs
prescription drugs
computational methodology
low probe sampling
GPCRs biological state
protein denaturation
known ligands
prospective studies
membrane distortion
membrane proteins
retrospective studies
developed protocols
computational procedures
small molecule ligands
discovery of lead compounds
successful class of druggable targets
cutting-edge enhanced sampling molecular dynamics simulation methods
complex
new opportunities
M3
structure-based computer aided methodologies
Âµ-opipid
interface
collaborative skills
P2Y
development of novel health technologies
CRF1
cost-intensive
time-consuming high-throughput screening
human genome
current limitations
identification of extracellular
experts
M2
Experience Researcher
academia
industry
collaboration
European Union
lipids
date
outcome